• Vk
  • LinkedIn
  • Youtube
X7 Research
  • News
  • Registration strategy and Сonsulting
    • Budgeting
    • Registration strategy development
    • Study feasibility
    • Vendor selection
    • Data search and analysis
  • Clinical trials
    • Outsourcing CRAs in Russia and the EAEU
    • Development of medical documentation and biostatistics
    • Monitoring
    • Data-management
    • Patient home visits
    • Bioequivalence study
    • Therapeutic equivalence studies
    • Clinical trials of medical devices
  • Registration
    • Audit of the registration dossier
    • Bringing the registration dossier in compliance with the requirements of the EAEU
    • Conversion of registration dossier into XML format
    • PIL readability user testing
    • Translation of the Registration dossier
    • Turnkey registration
  • Post-authorization clinical studies
    • Phase IV studies
    • Non-interventional studies
    • Investigator-initiated studies
    • Post-authorisation safety study
    • Marketing research
  • Pharmacovigilance
    • QPPV in the EAEU
    • Safety monitoring of medical devices
    • Building a pharmacovigilance system
    • Safety in clinical trials
    • Pharmacovigilance audit
    • Pharmacovigilance contact person
  • Therapeutic expertise
    • Clinical trials in Oncology in the EAEU
  • Contact
  • EnglishEnglish
    • РусскийРусский
  • Menu

Developing a registration strategy by EAEU requirements

22.06.2021/in Publications /by Marketing

Drug registration is a comprehensive, complex process that requires compliance with a large number of requirements and regulations. Fundamental principles of this process are reflected in the documents of the Eurasian Economic Commission. If you know all the regulatory issues and the nuances of drug registration procedures, you can develop a correct and effective strategy, without which the process of obtaining a registration certificate (RF) is impossible.

The main document to be guided in the development of the strategy is the Decision of the EEC Council № 78 of 03.11.2016 “On the Rules for Registration and Examination of Drugs for Medical Use”. It establishes the principles, procedure, terms of registration and examination of medicinal drugs, as well as the terms of circulation of medicinal drugs in the EAEU member states. And it includes information on the requirements for the registration dossier: the description of modules, forms of applications, reports, and other documents required for the registration of drugs.

The main stages, which have the most important strategic importance in the preparation of the registration dossier.

1.A description of the drug to be registered.

The strategy should begin with defining the registration group of the drug. By Annex 1 to the Registration Rules, the drug can be classified as original, reproduced, hybrid, bio-analog, or other groups. The classification determines the format of the submitted dossier and the entire subsequent strategy.

2. Choice of registration mechanism.

There are two mechanisms for state registration within the common market of the EEC.

Mutual recognition procedure. Registration is carried out only in one chosen EEC member-state (the reference state), with the possibility of further recognition in other EEC member-states at the request of the applicant.

Decentralized procedure. Registration is carried out simultaneously by several member-states, with the choice of the reference state.

3. Determination of the amount of data in the dossier.

It is necessary to provide information about all life cycles of the drug: scientific research, preclinical development, clinical development, pharmaceutical development, and manufacturing processes to obtain the RF.

4. Conducting research.

Our next step is to develop a plan for ongoing preclinical and clinical studies. Up-to-date documentation describing the requirements for conducting clinical trials can be found on the website of the Eurasian Economic Commission.

A correctly made strategy will allow: to make a plan of actions, determine the terms of all necessary stages in the preparation of the registration dossier, save the money, and successfully, with minimal costs, go through the registration of the medicinal product.

Our specialists have experience in this area and will be happy to help you develop a registration strategy for your drug

 

Share this entry
  • Share on Twitter
  • Share on WhatsApp
  • Share on Pinterest
  • Share on LinkedIn
  • Share on Tumblr
  • Share on Vk
  • Share on Reddit
  • Share by Mail

YOU MAY ALSO BE INTERESTED IN

Publications
Corrections to clinical trial documents due to COVID-19. Russian experience.
Read More
Publications
WHAT IS BIOEQUIVALENCE
Read More
Publications
THE VOLUME OF RUSSIAN PHARMACEUTICAL MARKET 2016-2019
Read More

RUBRICS

Registration strategy and Сonsulting

Clinical trials

Registration

Post-authorization clinical studies

Pharmacovigilance

LATEST PUBLICATIONS

  • Corrections to clinical trial documents due to COVID-19. Russian experience.
  • WHAT IS BIOEQUIVALENCE
  • THE VOLUME OF RUSSIAN PHARMACEUTICAL MARKET 2016-2019

Tags

bioequivalenceClinical trials in the CISfeasibilitymonitoringRadiopharmaceuticals

CONTACT

1 + 5 = ?

This contact form is deactivated because you refused to accept Google reCaptcha service which is necessary to validate any messages sent by the form.

PRIVACY

Use of this site constitutes your consent to our Privacy Policy.


SOCIAL RESPONSIBILITY

X7 Research’s primary responsibility is to help our clients in bringing medicines & products to the market efficiently and safely.

The Best CRO for Clinical Trials | Full-service Global CRO — X7 Research

The Best CRO in Pharma | Clinical Research Organisation — X7 Research

The Best Contract Research Organisation (CRO) | Trusted CRO — X7 Research

The Best Clinical Research Organisation (CRO): Full Service CRO | X7 Research

The Best CRO in Research | Trusted CRO for Your Trail — X7 Research

The Best Clinical Trial Company | Global Full-service CRO - X7 Research

The Best Pharma CROs: Clinical Trials for Drugs | X7 Research

The Best CROs Company: Clinical Trials with Global CRO — X7 Research

The Best Pre-clinical CRO: Safety Assessment With X7 Research

The Best Clinical Development | Trusted CRO for Your Product: X7 Research

The Best Biostatistical Consulting: Statistical Services | X7 Research

The Best Pharmacovigilance Consulting Services | CRO — X7 Research

Feasibility in Clinical Trials: What is a Feasibility in Clinical Trials?

Clinical Study Trials: What are Clinical Study Trials?

Category
Strategy and consulting
Clinical trials
Registration
Post-authorization clinical studies
Pharmacovigilance

Registration strategy and Сonsulting
Registration strategy development
Budgeting
Study feasibility
Vendor selection
Data search and analysis

Clinical trials
Development of medical documentation and biostatistics
Monitoring
Data management
Patient home visits
Bioequivalence study
Therapeutic equivalence studies

Registration
Audit of the registration dossier
Dossier eaeu
Conversion of registration dossier into xml format
Pil readability user testing
Turnkey registration

Post-authorization clinical studies
Phase iv studies
Non interventional studies
Investigator initiated studies
Post authorisation safety study
Marketing research

Pharmacovigilance
Building a pharmacovigilance system
Safety in clinical trials
Pharmacovigilance audit
Pharmacovigilance contact person

Blog
Contacts

© Copyright 2010-2023 - X7 Research. All rights reserved.
NIS data: work with the data array Remote clinical trial monitoring
Scroll to top